Neoteryx has been acquired by Trajan Group Holdings
Neoteryx, LLC has been sold to Trajan Group Holdings Limited.
Neoteryx, based in Southern California, is a global leader in blood micro-sampling, with operations in the USA and Europe. Its customers include scientific researchers, laboratories and health providers working to advance telemedicine, pharmaceutical development, biotechnology research and clinical diagnostics.
Trajan Group Holdings is a global developer and manufacturer of analytical and life sciences products and devices used in the analysis of biological, food, water and other environmental samples. The company has more than 520 employees, operating across the USA, Australia, Europe and Malaysia.
One of Oaklins’ teams in the USA served as the exclusive financial advisor to Neoteryx, LLC in this transaction.



Fasha Mahjoor
Founder and CEO, Neoteryx, LLC
Talk to the deal team

Michael S. Goldman
Managing Director
New York, United StatesOaklins TM Capital

James McLaren
Managing Director
New York, United StatesOaklins TM Capital

Related deals
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn moreSerenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.
Learn moreBiosynex has acquired Para’kito
Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.
Learn more